Top of page

IP & Commercial Transactions

Practice

Filters

CureVac $245.3 million IPO

Davis Polk advised CureVac N.V. on its $245.3 million initial public offering of 15,333,332 of its common shares, which…

Acutus Medical $170 million IPO

Davis Polk advised Acutus Medical, Inc. on its SEC-registered initial public offering of 10,147,058 shares of common stock…

Oak Street Health $377.3 million IPO

Davis Polk advised the joint book running managers in connection with the $377.3 million initial public offering of 17,968…
Back to top